<DOC>
	<DOC>NCT00883311</DOC>
	<brief_summary>The purpose of the study is to determine whether the topical application of BRT-FC-83C is effective in the treatment of mild to moderate atopic dermatitis.</brief_summary>
	<brief_title>A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis</brief_title>
	<detailed_description>Atopic dermatitis is a common skin disease. BRT-FC-83C is a skin cream that does not contain corticosteroids or other anti-inflammatory components. It represents a novel class of skin barrier repair therapy for chronic dermatoses. The objective of this clinical study is to determine whether BRT-FC-83C, applied twice a day to the affected area of the skin, ameliorates signs and symptoms of mild to moderate atopic dermatitis.</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinically verified mild to moderate atopic dermatitis. Atopy diagnosis based on clinical scores of 37.5 based on the Rajka and Langeland criteria Men or women ages 1850 years At least one mild to moderate atopic lesion involving no more than 20% Body Surface Area (BSA) Active atopic dermatitis for at least 3 years Willingness to cooperate and participate by following study requirements Written informed consent Individuals with actively oozing atopic lesions Individuals who are smokers Individuals with insulindependent diabetes mellitus Individuals that are known to be pregnant, nursing, or planning to become pregnant within the next six months after enrollment Individuals currently participating in another clinical usage study that would interfere with this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Efficacy</keyword>
</DOC>